Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

iBio (IBIO) EPS (Weighted Average and Diluted) (2021 - 2025)

iBio (IBIO) has disclosed EPS (Weighted Average and Diluted) for 10 consecutive years, with -$0.09 as the latest value for Q4 2025.

  • Quarterly EPS (Weighted Average and Diluted) rose 81.25% to -$0.09 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was -$1.0 through Dec 2025, up 63.24% year-over-year, with the annual reading at -$1.75 for FY2025, 73.08% up from the prior year.
  • EPS (Weighted Average and Diluted) for Q4 2025 was -$0.09 at iBio, up from -$0.11 in the prior quarter.
  • The five-year high for EPS (Weighted Average and Diluted) was -$0.04 in Q1 2021, with the low at -$68.43 in Q4 2022.
  • Average EPS (Weighted Average and Diluted) over 5 years is -$8.04, with a median of -$1.13 recorded in 2022.
  • The sharpest move saw EPS (Weighted Average and Diluted) tumbled 4957.98% in 2023, then surged 98.22% in 2024.
  • Over 5 years, EPS (Weighted Average and Diluted) stood at -$1.37 in 2021, then plummeted by 4894.89% to -$68.43 in 2022, then surged by 93.54% to -$4.42 in 2023, then soared by 89.14% to -$0.48 in 2024, then skyrocketed by 81.25% to -$0.09 in 2025.
  • According to Business Quant data, EPS (Weighted Average and Diluted) over the past three periods came in at -$0.09, -$0.11, and -$0.31 for Q4 2025, Q3 2025, and Q2 2025 respectively.